Recent Analysts’ Ratings Changes for PACS Group (PACS)

Several analysts have recently updated their ratings and price targets for PACS Group (NYSE: PACS):

• 5/14/2026 – PACS Group was downgraded by Zacks Research from “strong-buy” to “hold”.
• 5/13/2026 – PACS Group had its price target raised by Oppenheimer Holdings, Inc. from $42.00 to $48.00. They now have an “outperform” rating on the stock.
• 5/10/2026 – PACS Group was upgraded by Wall Street Zen from “hold” to “buy”.
• 5/2/2026 – PACS Group was downgraded by Wall Street Zen from “buy” to “hold”.
• 3/27/2026 – PACS Group had its “hold (c)” rating reaffirmed by Weiss Ratings.

Insider Buying and Selling at PACS Group

In other PACS Group news, COO Joshua Jergensen sold 36,335 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $34.28, for a total transaction of $1,245,563.80. Following the completion of the transaction, the chief operating officer owned 2,667,347 shares of the company’s stock, valued at approximately $91,436,655.16. This trade represents a 1.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 70.10% of the company’s stock.

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.